Table 1.
Demographic details of the total cohort and stenosis subgroups. SD: standard deviation; min: minimal; max: maximal; CAD: carotid artery disease comprising carotid artery stenosis (CAS) and carotid artery occlusion (CAO); HLP: hyperlipoproteinemia; PAD: peripheral artery disease; TIA: transient ischemic attack; Group 1: CAS 50–79%; Group 2: CAS ≥ 80% or CAO with nonretrograde OA; Group 3: CAS ≥ 80% or CAO with retrograde OA.
| Total cohort | Stenosis subgroups | |||
|---|---|---|---|---|
| Group 1 | Group 2 | Group 3 | ||
| Patients N | 27 | 8 | 7 | 12 |
| Sex | ||||
| Male | 17 (63%) | 7 (87.5%) | 2 (28.6%) | 8 (66.7%) |
| Female | 10 (37%) | 1 (12.5%) | 5 (71.4%) | 4 (33.3%) |
| Age (years) | ||||
| Mean ± SD | 61 ± 10 | 66 ± 4 | 62 ± 7 | 58 ± 12 |
| (min–max) | (35–76) | (61–72) | (50–71) | (35–76) |
| Disease duration CAD (months) | ||||
| Mean ± SD | 46 ± 50 | 21 ± 20 | 74 ± 55 | 46 ± 56 |
| (min–max) | (1–177) | (2–58) | (6–177) | (1–169) |
| Unilateral CAD | ||||
| 50–79% | 8 (29.6%) | 8 (100%) | 0 | 0 |
| 80–99% | 9 (33.3%) | 0 | 5 (71.4%) | 4 (33.3%) |
| Occlusion | 10 (37.0%) | 0 | 2 (28.6%) | 8 (66.7%) |
| Comorbidity | ||||
| Art. hypertension | 18 (66.7%) | 7 (87.5%) | 5 (71.4%) | 6 (50.0%) |
| HLP | 14 (51.9%) | 4 (50.0%) | 3 (42.9%) | 7 (58.3%) |
| Coronary artery disease | 8 (29.6%) | 4 (50.0%) | 1 (14.3%) | 3 (25.0%) |
| Diabetes mellitus | 4 (14.8%) | 2 (25.0%) | 1 (14.3%) | 1 (8.3%) |
| PAD | 3 (11.1%) | 1 (12.5%) | 1 (14.3%) | 1 (8.3%) |